Quad-Cities Times

Share

Quad-Cities Times

 •  July 20, 2017

A new gene therapy drug, the first in its class, was recommended for approval to the US Food and Drug Administration by an advisory committee on Wednesday. If approved by the FDA, the agency would consider it the first gene therapy to hit the market. The drug may provide a second chance to some leukemia patients whose first-line drugs have...

Quad-Cities Times

 •  June 25, 2017

The U.S. Food and Drug Administration (FDA) is tasked with an inglorious job. It digs through hundreds, if not thousands, of pages of clinical trial data to determine if an experimental drug or medical device effectively reaches its treatment goal without outweighing the risks involved with taking or using it. The FDA has formally done this task...

Quad-Cities Times

 •  May 19, 2017

According to the most recent 13-F filings, George Soros' namesake fund -- the Soros Fund Management -- bought 31,200 shares of the drugmaker Pfizer (NYSE: PFE) during the first quarter of 2017. Although this is admittedly a rather modest purchase for a fund of this size, and it's never a good idea to blindly follow in the tracks of any...

Quad-Cities Times

 •  March 30, 2017

A congressional committee once again has drugmakers in its crosshairs. This time, it's the U.S. Senate's Homeland Security and Governmental Affairs Committee investigating five opioid drugmakers to determine if the companies' practices have contributed to widespread painkiller overdoses in the U.S. Sen. Claire McCaskill (D-Mo.) sent letters to...